These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19907100)

  • 1. Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients.
    Miyashita Y; Endo K; Saiki A; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohira M; Oyama T; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):539-45. PubMed ID: 19907100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
    Miyashita Y; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohira M; Oyama T; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):621-6. PubMed ID: 19907103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients.
    Nagayama D; Saiki A; Endo K; Yamaguchi T; Ban N; Kawana H; Ohira M; Oyama T; Miyashita Y; Shirai K
    Int J Clin Pract; 2010 Dec; 64(13):1796-801. PubMed ID: 20946343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The administration of pitavastatin augments creatinine clearance associated with reduction in oxidative stress parameters: acute and early effects.
    Kakuda H; Kanasaki K; Koya D; Takekoshi N
    Clin Exp Nephrol; 2013 Apr; 17(2):240-7. PubMed ID: 22948417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAVI-Lowering Effect of Pitavastatin May Be Involved in the Prevention of Cardiovascular Disease: Subgroup Analysis of the TOHO-LIP.
    Saiki A; Watanabe Y; Yamaguchi T; Ohira M; Nagayama D; Sato N; Kanayama M; Takahashi M; Shimizu K; Moroi M; Miyashita Y; Shirai K; Tatsuno I
    J Atheroscler Thromb; 2021 Oct; 28(10):1083-1094. PubMed ID: 33342941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
    Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
    Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus.
    Yamaguchi T; Shirai K; Nagayama D; Nakamura S; Oka R; Tanaka S; Watanabe Y; Imamura H; Sato Y; Kawana H; Ohira M; Saiki A; Shimizu N; Tatsuno I
    J Atheroscler Thromb; 2019 Jul; 26(7):659-669. PubMed ID: 30584220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice.
    Matsumoto M; Tanimoto M; Gohda T; Aoki T; Murakoshi M; Yamada K; Yamazaki T; Kaneko S; Horikoshi S; Tomino Y
    Metabolism; 2008 May; 57(5):691-7. PubMed ID: 18442635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between urinary 8-OHdG and pulse wave velocity in hypertensive patients with type 2 diabetes mellitus.
    Kotani K; Yamada T
    Singapore Med J; 2014 Apr; 55(4):202-8. PubMed ID: 24763836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin: clinical effects from the LIVES Study.
    Teramoto T
    Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement.
    Tsubouchi H; Inoguchi T; Sonta T; Sato N; Sekiguchi N; Kobayashi K; Sumimoto H; Utsumi H; Nawata H
    Free Radic Biol Med; 2005 Aug; 39(4):444-52. PubMed ID: 16043016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ezetimibe monotherapy on lipid metabolism and arterial stiffness assessed by cardio-ankle vascular index in type 2 diabetic patients.
    Miyashita Y; Endo K; Saiki A; Ban N; Nagumo A; Yamaguchi T; Kawana H; Nagayama D; Ohira M; Oyama T; Shirai K
    J Atheroscler Thromb; 2010 Oct; 17(10):1070-6. PubMed ID: 20644331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal protective effects of pitavastatin on spontaneously hypercholesterolaemic Imai Rats.
    Liang XM; Otani H; Zhou Q; Tone Y; Fujii R; Mune M; Yukawa S; Akizawa T
    Nephrol Dial Transplant; 2007 Aug; 22(8):2156-64. PubMed ID: 17550926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes.
    Goodarzi MT; Navidi AA; Rezaei M; Babahmadi-Rezaei H
    J Clin Lab Anal; 2010; 24(2):72-6. PubMed ID: 20333759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Ueda S; Fukami K; Okuda S; Yamagishi S
    Pharmacol Res; 2010 Jan; 61(1):58-61. PubMed ID: 19666118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.
    Huang CH; Huang YY; Hsu BR
    J Diabetes Investig; 2016 Sep; 7(5):769-76. PubMed ID: 27181110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.
    Kawai Y; Sato-Ishida R; Motoyama A; Kajinami K
    Drug Des Devel Ther; 2011; 5():283-97. PubMed ID: 21625418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of body weight reduction on cardio-ankle vascular index (CAVI).
    Nagayama D; Endo K; Ohira M; Yamaguchi T; Ban N; Kawana H; Nagumo A; Saiki A; Oyama T; Miyashita Y; Shirai K
    Obes Res Clin Pract; 2013; 7(2):e139-e145. PubMed ID: 24331775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy.
    Serdar M; Sertoglu E; Uyanik M; Tapan S; Akin K; Bilgi C; Kurt I
    Free Radic Res; 2012 Oct; 46(10):1291-5. PubMed ID: 22789030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.